Biopharmaceuticals
Reimbursement
Product Launch
News Release - November 29, 2016
Cardiome Advances Toward the UK XYDALBA(TM) (dalbavancin) Launch
Source: Cardiome Pharma
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.